NCT02315001View on ClinicalTrials.gov

Liraglutide to Improve corONary Haemodynamics During Exercise streSS

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Ischaemic Heart DiseaseCoronary Heart DiseaseChronic Stable Angina
Interventions
DRUG

Liraglutide

GLP-1 receptor agonist administered via subcutaneous injection

OTHER

Placebo

Volume-matched normal saline placebo administered via subcutaneous injection

Trial Locations (1)

SE17EH

Guy's and St Thomas' NHS Foundation Trust, London

All Listed Sponsors
collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

lead

King's College London

OTHER

NCT02315001 - Liraglutide to Improve corONary Haemodynamics During Exercise streSS | Biotech Hunter | Biotech Hunter